Related Experiment Videos
[Verification of desferrioxamine ototoxicity by high-frequency audiometry in patients undergoing dialysis]
1Hospital General De Galicia, Facultad de Medicina, Universidad de Santiago, Santiago de Compostela.
Anales Otorrinolaringologicos Ibero-Americanos
|January 1, 1994
Abstract:
The AA. have studied the Desferrioxamine ototoxicity with high frequency audiometry (HFA), given the drug as a test for diagnosis of aluminium-related done disease in patients under dialysis. The dose of 10 mg/kg presents high sensitivity and low ototoxicity.